Hepatitis C Genotype 1 Cured With 4 Weeks of Pegylated Interferon, Ribavirin, and Sofosbuvir

被引：0
|
作者：
Habibullah, Masud [1 ]
Bunim, Ari [1 ]
Rubin, Moshe [1 ]
机构：
[1] New York Hosp Queens, Flushing, NY USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2014年 / 109卷
关键词：
D O I：
10.14309/00000434-201410002-00519
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
519
引用
收藏
页码：S153 / S153
页数：1
相关论文
共 50 条
  • [1] Merimepodib, Pegylated Interferon, and Ribavirin in Genotype 1 Chronic Hepatitis C Pegylated Interferon and Ribavirin Nonresponders
    Rustgi, Vinod K.
    Lee, William M.
    Lawitz, Eric
    Gordon, Stuart C.
    Afdhal, Nezam
    Poordad, Fred
    Bonkovsky, Herbert L.
    Bengtsson, Leif
    Chandorkar, Gurudatt
    Harding, Matthew
    McNair, Lindsay
    Aalyson, Molly
    Alam, John
    Kauffman, Robert
    Gharakhanian, Shahin
    McHutchison, John G.
    [J]. HEPATOLOGY, 2009, 50 (06) : 1719 - 1726
  • [2] Sofosbuvir, pegylated interferon, and ribavirin for retreatment of hepatitis C virus genotype 1b following sofosbuvir and ledipasvir failure
    Kalal, Chetan
    Shukla, Akash
    Mohanka, Ravi
    Vora, Mihir
    Patel, Priyesh
    Shah, Samir
    [J]. HEPATOLOGY, 2018, 67 (05) : 2049 - 2050
  • [3] Effectiveness of sofosbuvir/pegylated-interferon plus ribavirin in treatment of hepatitis C virus genotype 4 patients
    Abdel-Moneim, Adel
    Abood, Alaa
    Abdel-Gabaar, Mohamed
    Zanaty, Mohamed I.
    Ramadan, Mohamed
    [J]. CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2018, 4 (03) : 191 - 196
  • [4] Sofosbuvir and Ribavirin With or Without Pegylated Interferon for Hepatitis C Genotype 3: A Real World Experience
    Abbas, Zaigham
    Saad, Muhammad
    Nadeem, Ramlah
    Jawed, Fahad
    Abbas, Minaam
    [J]. HEPATITIS MONTHLY, 2017, 17 (04)
  • [5] Comparison of Sofosbuvir Plus Ribavirin Treatment with Pegylated Interferon Plus Ribavirin Treatment for Chronic Hepatitis C Genotype 2
    Seo, Kayo
    Kim, Soo Ki
    Kim, Soo Ryang
    Ohtani, Aya
    Kobayashi, Mana
    Kato, Airi
    Morimoto, Eri
    Saijo, Yuka
    Kim, Ke Ih
    Imoto, Susumu
    Kim, Chi Wan
    Yano, Yoshihiko
    Kudo, Masatoshi
    Hayashi, Yoshitake
    [J]. DIGESTIVE DISEASES, 2017, 35 (06) : 541 - 547
  • [6] Microalbuminuria in hepatitis C-genotype 4:Effect of pegylated interferon and ribavirin
    Moutaz Derbala
    Fatma M Shebl
    Awad Rashid
    Aliaa Amer
    Abdulbari Bener
    [J]. World Journal of Gastroenterology, 2010, 16 (10) : 1226 - 1231
  • [7] Microalbuminuria in hepatitis C-genotype 4: Effect of pegylated interferon and ribavirin
    Derbala, Moutaz
    Shebl, Fatma M.
    Rashid, Awad
    Amer, Aliaa
    Bener, Abdulbari
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (10) : 1226 - 1231
  • [8] Hepatitis C genotype 4 response rate to pegylated interferon and ribavirin treatment in Belgium is similar to genotype 1
    de Galocsy, C.
    Kaufman, L.
    Tomasovic, S.
    Delwaide, J.
    Nevens, F.
    [J]. ACTA GASTRO-ENTEROLOGICA BELGICA, 2010, 73 (02): : 229 - 234
  • [9] Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection
    Legrand-Abravanel, F
    Nicot, F
    Boulestin, A
    Sandres-Sauné, K
    Vinel, JP
    Alric, L
    Izopet, J
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2005, 77 (01) : 66 - 69
  • [10] Pegylated interferon and ribavirin for the recurrence of chronic hepatitis C genotype 1 in transplant patients
    Oton, E
    Barcena, R
    Garcia-Garzon, S
    Moreno-Zamora, A
    Moreno, A
    Garcia-Gonzalez, M
    Blesa, C
    Foruny, JR
    Ruiz, P
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (09) : 3963 - 3964
12345